Drug Utilization Review (DUR) Board

Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

About the Board   Board Meetings  

October 27, 2021 Agenda

  • October 27, 2021 DUR Board Meeting

  • Meeting Time:  1:00 P.M.

  • WebEx: 1-415-655-0001

  • Meeting Number (access code):2467 491 6211


DUR Board Minutes 2016-2021